U.S. Markets closed

Isracann Biosciences Inc. (ISCNF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.1946+0.0120 (+6.57%)
At close: 12:59PM EST

Isracann Biosciences Inc.

595 Burrard Street
Suite 1600
Vancouver, BC V7X 1L3
Canada
855 205 0226
http://www.isracann.com

Sector(s)Healthcare
IndustryDrug Manufacturers—Specialty & Generic
Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Ms. Yana Popova CPACFO, Corp. Sec. & DirectorN/AN/A1982
Mr. Darryl JonesPres, CEO & DirectorN/AN/A1983
Mr. Matt ChattertonChief Operating OfficerN/AN/AN/A
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Isracann Biosciences Inc., together with its subsidiaries, cultivates and produces medical cannabis in Israel and internationally. It also provides property development, facility design and construction, cultivation and processing, administrative, and technology licensing services. The company was formerly known as Atlas Blockchain Group Inc. and changed its name to Isracann Biosciences Inc. in October 2019. Isracann Biosciences Inc. was founded in 2010 and is headquartered in Vancouver, Canada.

Corporate Governance

Isracann Biosciences Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.